EMLAX | TRZFX | EMLAX / TRZFX | |
Total Expense Ratio | 1.10 | 0.00 | - |
Annual Report Gross Expense Ratio | 1.26 | 0.77 | 164% |
Fund Existence | 14 years | 4 years | - |
Gain YTD | 7.562 | 6.690 | 113% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 447M | 279M | 160% |
Annual Yield % from dividends | 5.41 | 7.16 | 76% |
Returns for 1 year | 8.90 | 7.80 | 114% |
Returns for 3 years | 17.20 | 19.30 | 89% |
Returns for 5 years | 17.97 | N/A | - |
Returns for 10 years | 13.65 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IIF | 26.08 | 0.14 | +0.54% |
Morgan Stanley India Investment Fund | |||
HDV | 115.18 | 0.52 | +0.45% |
iShares Core High Dividend ETF | |||
AVSE | 51.84 | 0.23 | +0.44% |
Avantis Responsible Emerging Mkts Eq ETF | |||
XNTK | 196.17 | 0.82 | +0.42% |
SPDR® NYSE Technology ETF | |||
NOVZ | 38.49 | N/A | N/A |
TrueShares Structured Outcome Nov ETF |